Arch Therapeutics Stock Analysis
| ARTH Stock | USD 1.13 0.38 25.17% |
Arch Therapeutics is overvalued with Real Value of 1.45 and Hype Value of 1.51. The main objective of Arch Therapeutics otc analysis is to determine its intrinsic value, which is an estimate of what Arch Therapeutics is worth, separate from its market price. There are two main types of Arch Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Arch Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Arch Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Arch Therapeutics otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Arch Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Arch OTC Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Arch Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Arch |
Arch OTC Stock Analysis Notes
About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.02. Arch Therapeutics had not issued any dividends in recent years. The entity had 1:200 split on the 18th of January 2023. Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company was founded in 2006 and is based in Framingham, Massachusetts. Arch Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.The quote for Arch Therapeutics is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Arch Therapeutics please contact Terrence Norchi at 617 431 2313 or go to https://www.archtherapeutics.com.Arch Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Arch Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Arch Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Arch Therapeutics generated a negative expected return over the last 90 days | |
| Arch Therapeutics has high historical volatility and very poor performance | |
| Arch Therapeutics may become a speculative penny stock | |
| The company currently holds 2.81 M in liabilities with Debt to Equity (D/E) ratio of 2.62, implying the company greatly relies on financing operations through barrowing. Arch Therapeutics has a current ratio of 0.8, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Arch Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Arch Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Arch Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Arch to invest in growth at high rates of return. When we think about Arch Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 15.65 K. Net Loss for the year was (5.28 M) with loss before overhead, payroll, taxes, and interest of (35.84 K). | |
| Arch Therapeutics currently holds about 55 K in cash with (4.46 M) of positive cash flow from operations. | |
| Roughly 15.0% of Arch Therapeutics shares are held by company insiders |
Arch Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arch Therapeutics's market, we take the total number of its shares issued and multiply it by Arch Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 15th of April 2024, Arch Therapeutics shows the mean deviation of 5.58, and Risk Adjusted Performance of (0.11). Arch Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Arch Therapeutics, which can be compared to its peers. Please confirm Arch Therapeutics risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Arch Therapeutics is priced correctly, providing market reflects its regular price of 1.13 per share. Given that Arch Therapeutics is a hitting penny stock territory we recommend to closely look at its jensen alpha.Arch Therapeutics Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Arch Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Arch Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Arch Therapeutics Predictive Daily Indicators
Arch Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Arch Therapeutics otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 2404.75 | |||
| Daily Balance Of Power | (1.03) | |||
| Rate Of Daily Change | 0.75 | |||
| Day Median Price | 1.32 | |||
| Day Typical Price | 1.25 | |||
| Price Action Indicator | (0.38) | |||
| Period Momentum Indicator | (0.38) |
Arch Therapeutics Forecast Models
Arch Therapeutics' time-series forecasting models are one of many Arch Therapeutics' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arch Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Arch OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Arch Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arch shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Arch Therapeutics. By using and applying Arch OTC Stock analysis, traders can create a robust methodology for identifying Arch entry and exit points for their positions.
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company was founded in 2006 and is based in Framingham, Massachusetts. Arch Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Arch Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arch Therapeutics. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Arch OTC Stock analysis
When running Arch Therapeutics' price analysis, check to measure Arch Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Therapeutics is operating at the current time. Most of Arch Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arch Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Therapeutics' price. Additionally, you may evaluate how the addition of Arch Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |